Loading...
Some patients requiring chronic oral anticoagulation for atrial fibrillation or mechanical heart valves undergo coronary stenting and are subsequently given aspirin and clopidogrel — in addition to the anticoagulant — to prevent stent thrombosis. However, triple antithrombotic therapy carries an increased risk for bleeding.
In an open-label, European, multicenter trial, investigators randomized 573 adults taking anticoagulants (mean age, 70; 20% women) to receive clopidogrel alone (double therapy) or clopidogrel plus aspirin (triple therapy) after coronary stenting (radial access, 25%; bare-metal stents, approximately one third).
At 1-year follow-up, the primary outcome of any bleeding episode occurred in 19.4% of double-therapy recipients an…